Uenaka A, Kuribayashi K, Nakayama E
Department of Tumor Immunology, Center for Adult Diseases, Osaka, Japan.
Transpl Immunol. 1993;1(2):132-6. doi: 10.1016/0966-3274(93)90006-t.
Roles of CD8+ and CD4+ cells on lethal graft-versus-host disease (GVHD) were investigated. Injection of spleen cells from C57BL/6 (B6) female mice into (BALB/c x B6)F1 nu/nu female mice caused subacute lethal GVHD (survival: 10-50 days). Injection of anti-Lyt-2.2 (CD8) monoclonal antibody (mAb) on days zero, four and 14 into recipient mice prolonged their survival for at least the 200-day observation period. Injection of anti-L3T4 (CD4) mAb also prolonged survival of the mice for more than 70 days, but they eventually died by 150 days. Pretreatment of the donor B6 spleen cells with anti-Lyt-2.2 (CD8) mAb and complement (C) prevented the development of GVHD, and their pretreatment with anti-L3T4 (CD4) mAb and C markedly prolonged the survival of recipient mice. Injection of a mixture of donor spleen cells pretreated with anti-Lyt-2.2 (CD8) mAb and C and those pretreated with anti-L3T4 (CD4) mAb and C induced subacute lethal GVHD. Injection of anti-L3T4 (CD4) mAb, but not anti-Lyt-2.2 (CD8) mAb on days five, nine and 14 prolonged survival of the recipient mice. These results indicated that the collaboration of CD8+ cells and CD4+ cells was necessary for induction of subacute lethal GVHD. CD4+ cells but not CD8+ cells were involved in mediating subacute GVHD from the onset of the disease. CD8+ cells were, however, capable of inducing late-onset lethal GVHD. Direct phenotyping of T cells in the recipient mice revealed that the CD4+ cells were incapable of repopulating without CD8+ cells, but that CD8+ cells were capable of repopulating without CD4+ cells.
研究了CD8⁺和CD4⁺细胞在致死性移植物抗宿主病(GVHD)中的作用。将C57BL/6(B6)雌性小鼠的脾细胞注射到(BALB/c×B6)F1裸/裸雌性小鼠中会导致亚急性致死性GVHD(存活时间:10 - 50天)。在第0、4和14天向受体小鼠注射抗Lyt-2.2(CD8)单克隆抗体(mAb)可使它们的存活期延长至少200天的观察期。注射抗L3T4(CD4)mAb也使小鼠存活期延长超过70天,但它们最终在150天时死亡。用抗Lyt-2.2(CD8)mAb和补体(C)对供体B6脾细胞进行预处理可防止GVHD的发生,用抗L3T4(CD4)mAb和C对其进行预处理可显著延长受体小鼠的存活期。注射用抗Lyt-2.2(CD8)mAb和C预处理的供体脾细胞与用抗L3T4(CD4)mAb和C预处理的供体脾细胞的混合物会诱导亚急性致死性GVHD。在第5、9和14天注射抗L3T4(CD4)mAb而非抗Lyt-2.2(CD8)mAb可延长受体小鼠的存活期。这些结果表明,CD8⁺细胞和CD4⁺细胞的协作对于诱导亚急性致死性GVHD是必要的。从疾病发作开始,CD4⁺细胞而非CD8⁺细胞参与介导亚急性GVHD。然而,CD8⁺细胞能够诱导迟发性致死性GVHD。对受体小鼠中的T细胞进行直接表型分析显示,CD4⁺细胞在没有CD8⁺细胞的情况下无法重建,但CD8⁺细胞在没有CD4⁺细胞的情况下能够重建。